Clinical Trial Update: Personalized Warfarin Dosing by Genomics and Computational Intelligence [NA]

View source ↗

Summary

An update on a trial evaluating personalized warfarin dosing using genomics and computational intelligence. The study was terminated and results were posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Myocardial Infarction
• Venous Thromboembolism

Drugs mentioned

• Warfarin (Coumadin) (warfarin)

Snippet

Sponsor: US Department of Veterans Affairs | Conditions: Venous Thrombosis, Atrial Fibrillation | NA | Status: TERMINATED | Results posted: 2014-02-24